ArticleFrontiers in genetics2019
Effective Diagnosis of Alzheimer's Disease
Article in Frontiers in genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Interpretable multimodal MRI fusion in Alzheimer's disease classification using extended parallel multilink joint ICA and 3D ResNet.iScience · 2026Article
- Interpretable integration of unpaired multi-omics for Alzheimer's diagnosis via cross-modal transformer reconstruction.PLoS computational biology · 2026Article
- Early diagnosis and developmental outcome prediction of agenesis of the corpus callosum via an interpretable deep multimodal fusion model.Frontiers in neuroscience · 2026Article
- Conventional and Emerging Drug Targeting Sites in Alzheimer's Disease and the Role of Translational Informatics in its Diagnosis and Management.Current neuropharmacology · 2025Review
- CNTNAP2 Protein Is Degraded by the Ubiquitin-Proteasome System and the Macroautophagy-Lysosome Pathway.Molecular neurobiology · 2023Article
- AI-Aided Disease Prediction in Visualized Medicine.Advances in experimental medicine and biology · 2023Article
- Deep multiview learning to identify imaging-driven subtypes in mild cognitive impairment.BMC bioinformatics · 2022Article
- A review of brain imaging biomarker genomics in Alzheimer's disease: implementation and perspectives.Translational neurodegeneration · 2022Review
- Multimodal Brain Connectomics-Based Prediction of Parkinson's Disease Using Graph Attention Networks.Frontiers in neuroscience · 2021Article
- Machine learning for the life-time risk prediction of Alzheimer's disease: a systematic review.Brain communications · 2021Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's disease (AD) is a complex neurodegenerative disease involving a variety of pathogenic factors, and the etiology detection of this disease has been a major concern of researchers. Neuroimaging is a basic and important means to explore the problem. It is the main current scientific research direction for combining neuroimaging with other modal data to dig deep into the potential information of AD through the complementarities among multiple data points. Machine learning methods possess great potentiality and have reached some achievements in this research area. A few studies have proposed some solutions to the effects of multimodal data fusion, however, the overall analytical framework for data fusion and fusion result analysis has thus far been ignored. In this paper, we first put forward a novel multimodal data fusion method, and further present a new machine learning framework of data fusion, classification, feature selection, and disease-causing factor extraction. The real dataset of 37 AD patients and 35 normal controls (NC) with functional magnetic resonance imaging (fMRI) and genetic data was used to verify the effectiveness of the framework, which was more accurate in classification and optimal feature extraction than other methods. Furthermore, we revealed disease-causing brain regions and genes, such as the olfactory cortex, insula, posterior cingulate gyrus, lingual gyrus, CNTNAP2, LRP1B, FRMD4A, and DAB1. The results show that the machine learning framework could effectively perform multimodal data fusion analysis, providing new insights and perspectives for the diagnosis of Alzheimer's disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.